Dilated cardiomyopathy, focus on new LAMP2 gene mutations and their clinical manifestations, a case report

Abstract

Dilated cardiomyopathies are a group of heterogeneous myocardial disorders characterized by ventricular dilatation and impaired contractility in the absence of abnormal loading conditions. One of their most common complications is heart failure and sudden cardiac death (1). Their prevalence is estimated to be between 1 in 2,500 individuals, with an incidence of 7 per 100,000 people, and men are more frequently affected than women, in a 3:1 ratio.